Gilead voluntarily withdraws urothelial cancer drug in US-February 2024-www.financetom.com

Gilead voluntarily withdraws urothelial cancer drug in US

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Gilead voluntarily withdraws urothelial cancer drug in US

Oct 18, 2024 6:16 AM

Oct 18 (Reuters) - Gilead Sciences ( GILD ) said on

Friday it was voluntarily withdrawing the U.S. approval for

Trodelvy in previously treated patients with a type of

urothelial cancer after consultation with the regulator.

(Reporting by Sneha S K)

Previous page： Healthcare firm Concentra prices US IPO at nearly $3 billion valuation Next page： Japan's Honda to close China plant, halt production at another factory

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Healthcare firm Concentra prices US IPO at nearly $3 billion valuation

Jul 24, 2024

(Reuters) - Concentra Group set the pricing of its U.S. initial public offering (IPO) at a valuation of $2.97 billion, the U.S. healthcare firm said on Wednesday. The company, which is a unit of Select Medical ( SEM ) , priced its IPO at $23.5 apiece, close to the lower end of its targeted range of $23 to $26. It...

Japan's Honda to close China plant, halt production at another factory

Jul 24, 2024

(Reuters) -Japan's Honda Motor will close a factory in China and halt vehicle production at another plant, the automaker said on Thursday, as it seeks to start producing more electric vehicles amid heavy competition from Chinese brands. Honda will close a plant operated through its joint venture (JV) with Chinese state-owned automaker Guangzhou Automobile Group in October, a company spokesperson...

BRIEF-Peijia Medical Announces Acquisition Of Licensing Partner By Edwards Lifesciences

Jul 24, 2024

July 25 (Reuters) - Peijia Medical Ltd ( PEJMF ): * ACQUISITION OF COMPANY'S LICENSING PARTNER JENAVALVE TECHNOLOGY, INC. BY EDWARDS LIFESCIENCES ( EW ) * EDWARDS LIFESCIENCES TO ACQUIRE JENAVALVE BY WAY OF A MERGER Further company coverage: ...

India Morning Newsletter, July 25

Jul 24, 2024

To access a PDF version of this newsletter, please click here If you would like to receive this newsletter via email, please register at: https://solutions.refinitiv.com/MNCIndiaSubscriptionpage For an index of our newsletters click on ...